{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:09:48Z","timestamp":1791947388779,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773331"],"award-info":[{"award-number":["81773331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Initiative for Innovative Medicine","doi-asserted-by":"crossref","award":["2017-I2M-B&R-01"],"award-info":[{"award-number":["2017-I2M-B&R-01"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Capitals Funds for Health Improvement and Research","award":["2016-2-4018"],"award-info":[{"award-number":["2016-2-4018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psoriasis is a chronic immune\u2010mediated skin disorder. Systemic inflammation plays an important role in the pathogenesis of psoriasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 477 patients with psoriasis vulgaris (PsV,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009347), generalized pustular psoriasis (GPP,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200937), erythrodermic psoriasis (PsE,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200945), arthritic psoriasis (PsA,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200925) and mixed psoriasis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200923), and 954 healthy control subjects were included in the study. Demographic, clinical, and laboratory information were collected and compared between subgroups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the healthy control group, patients with psoriasis had higher total white blood cell (WBC), neutrophil, platelet counts, neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR), but lower hemoglobin (Hb) levels, lymphocyte and red blood cell (RBC) counts. NLR values in the PsV group were significantly lower than those in the GPP, PsE, and PsA groups, with GPP group being the highest. PLR values in the PsV group were significantly lower than those in the GPP, PsE, and PsA groups. There was no significant correlation between the psoriasis area severity index (PASI) score and either the NLR or PLR in the PsV group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated NLR and PLR were associated with psoriasis and differed between subtypes, suggesting that they could be used as markers of systemic inflammation in psoriasis patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12865-021-00454-4","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T11:02:55Z","timestamp":1632654175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients"],"prefix":"10.1186","volume":"22","author":[{"given":"Wen-Ming","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Meng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"issue":"3","key":"454_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/BOR.0000000000000274","volume":"28","author":"CT Ritchlin","year":"2016","unstructured":"Ritchlin CT, Krueger JG. New therapies for psoriasis and psoriatic arthritis. Curr Opin Rheumatol. 2016;28(3):204\u201310.","journal-title":"Curr Opin Rheumatol"},{"issue":"4\u20135","key":"454_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","volume":"13","author":"SK Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SK, Maverakis E, Raychaudhuri SP. Diagnosis and classification of psoriasis. Autoimmun Rev. 2014;13(4\u20135):490\u20135.","journal-title":"Autoimmun Rev"},{"key":"454_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10238-018-0538-x","volume":"19","author":"P Paliogiannis","year":"2018","unstructured":"Paliogiannis P, Satta R, Deligia G, Farina G, Bassu S, Mangoni AA, Carru C, Zinellu A. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med. 2018;19:37\u201345.","journal-title":"Clin Exp Med"},{"issue":"Suppl 2","key":"454_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2133.2008.08780.x","volume":"159","author":"F Spah","year":"2008","unstructured":"Spah F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol. 2008;159(Suppl 2):10\u20137.","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"454_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","volume":"26","author":"K Reich","year":"2012","unstructured":"Reich K. The concept of psoriasis as a systemic inflammation: implications for disease management. J Eur Acad Dermatol Venereol. 2012;26(Suppl 2):3\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"454_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13104-016-2335-5","volume":"10","author":"P Forget","year":"2017","unstructured":"Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10(1):12.","journal-title":"BMC Res Notes"},{"issue":"10","key":"454_CR7","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/1346-8138.13875","volume":"44","author":"A Asahina","year":"2017","unstructured":"Asahina A, Kubo N, Umezawa Y, Honda H, Yanaba K, Nakagawa H. Neutrophil\u2013lymphocyte ratio, platelet\u2013lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics. J Dermatol. 2017;44(10):1112\u201321.","journal-title":"J Dermatol"},{"issue":"1","key":"454_CR8","doi-asserted-by":"publisher","first-page":"e13037","DOI":"10.1111\/eci.13037","volume":"49","author":"GL Erre","year":"2019","unstructured":"Erre GL, Paliogiannis P, Castagna F, Mangoni AA, Carru C, Passiu G, Zinellu A. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Investig. 2019;49(1):e13037.","journal-title":"Eur J Clin Investig"},{"issue":"Suppl 1","key":"454_CR9","doi-asserted-by":"publisher","first-page":"S127","DOI":"10.1016\/j.dsx.2016.12.021","volume":"11","author":"C Mertoglu","year":"2017","unstructured":"Mertoglu C, Gunay M. Neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus. Diabetes Metab Syndr. 2017;11(Suppl 1):S127\u201331.","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"454_CR10","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/echo.12511","volume":"31","author":"M Yurtdas","year":"2014","unstructured":"Yurtdas M, Yaylali YT, Kaya Y, Ozdemir M, Ozkan I, Aladag N. Neutrophil-to-lymphocyte ratio may predict subclinical atherosclerosis in patients with psoriasis. Echocardiography. 2014;31(9):1095\u2013104.","journal-title":"Echocardiography"},{"issue":"4","key":"454_CR11","first-page":"97","volume":"26","author":"M Polat","year":"2017","unstructured":"Polat M, Bugdayci G, Kaya H, Oguzman H. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis. Acta Dermatovenerol Alp Pannonica Adriat. 2017;26(4):97\u2013100.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"3","key":"454_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1346-8138.13061","volume":"43","author":"DS Kim","year":"2016","unstructured":"Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM, Lee MG. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016;43(3):305\u201310.","journal-title":"J Dermatol"},{"issue":"5","key":"454_CR13","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/ar4325","volume":"15","author":"MJ Kaplan","year":"2013","unstructured":"Kaplan MJ. Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther. 2013;15(5):219.","journal-title":"Arthritis Res Ther"},{"key":"454_CR14","doi-asserted-by":"publisher","first-page":"31119","DOI":"10.1038\/srep31119","volume":"6","author":"SC Hu","year":"2016","unstructured":"Hu SC, Yu HS, Yen FL, Lin CL, Chen GS, Lan CC. Neutrophil extracellular trap formation is increased in psoriasis and induces human beta-defensin-2 production in epidermal keratinocytes. Sci Rep. 2016;6:31119.","journal-title":"Sci Rep"},{"issue":"7","key":"454_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.autrev.2015.03.002","volume":"14","author":"B Pinegin","year":"2015","unstructured":"Pinegin B, Vorobjeva N, Pinegin V. Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity. Autoimmun Rev. 2015;14(7):633\u201340.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"454_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1111\/exd.13746","volume":"27","author":"H Katayama","year":"2018","unstructured":"Katayama H. Development of psoriasis by continuous neutrophil infiltration into the epidermis. Exp Dermatol. 2018;27(10):1084\u201391.","journal-title":"Exp Dermatol"},{"issue":"4","key":"454_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.5455\/msm.2014.231-233","volume":"26","author":"A Ataseven","year":"2014","unstructured":"Ataseven A, Bilgin AU, Kurtipek GS. The importance of neutrophil lymphocyte ratio in patients with psoriasis. Mater Sociomed. 2014;26(4):231\u20133.","journal-title":"Mater Sociomed"},{"issue":"4","key":"454_CR18","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jcct.2020.12.006","volume":"15","author":"AK Dey","year":"2021","unstructured":"Dey AK, Teague HL, Adamstein NH, Rodante JA, Playford MP, Chen MY, Bluemke DA, Gelfand JM, Ridker PM, Mehta NN. Association of neutrophil-to-lymphocyte ratio with non-calcified coronary artery burden in psoriasis: findings from an observational cohort study. J Cardiovasc Comput Tomogr. 2021;15(4):372\u20139.","journal-title":"J Cardiovasc Comput Tomogr"},{"issue":"6","key":"454_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5021\/ad.2019.31.6.601","volume":"31","author":"E Aktas Karabay","year":"2019","unstructured":"Aktas Karabay E, Aksu Cerman A, Demir D, Kivanc Altunay I. The effects of systemic psoriasis therapies on the C-reactive protein and the neutrophil\u2013lymphocyte ratio. Ann Dermatol. 2019;31(6):601\u201310.","journal-title":"Ann Dermatol"},{"issue":"2","key":"454_CR20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5114\/ada.2020.94838","volume":"37","author":"I An","year":"2020","unstructured":"An I, Ucmak D, Ozturk M. The effect of biological agent treatment on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in psoriasis patients. Postepy Dermatol Alergol. 2020;37(2):202\u20136.","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"454_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10238-018-0538-x","volume":"19","author":"P Paliogiannis","year":"2019","unstructured":"Paliogiannis P, Satta R, Deligia G, Farina G, Bassu S, Mangoni AA, Carru C, Zinellu A. Associations between the neutrophil-to-lymphocyte and the platelet-to-lymphocyte ratios and the presence and severity of psoriasis: a systematic review and meta-analysis. Clin Exp Med. 2019;19(1):37\u201345.","journal-title":"Clin Exp Med"},{"issue":"3","key":"454_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcla.21673","volume":"28","author":"S Zareifar","year":"2014","unstructured":"Zareifar S, Farahmand Far MR, Golfeshan F, Cohan N. Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP. J Clin Lab Anal. 2014;28(3):245\u20138.","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"454_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jdermsci.2008.08.019","volume":"53","author":"N Katoh","year":"2009","unstructured":"Katoh N. Platelets as versatile regulators of cutaneous inflammation. J Dermatol Sci. 2009;53(2):89\u201395.","journal-title":"J Dermatol Sci"},{"issue":"3\u20134","key":"454_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/mic.10.3-4.335.350","volume":"10","author":"AR Gear","year":"2003","unstructured":"Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation. 2003;10(3\u20134):335\u201350.","journal-title":"Microcirculation"},{"issue":"2","key":"454_CR25","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","volume":"73","author":"J Baliwag","year":"2015","unstructured":"Baliwag J, Barnes DH, Johnston A. Cytokines in psoriasis. Cytokine. 2015;73(2):342\u201350.","journal-title":"Cytokine"},{"issue":"7","key":"454_CR26","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/1756-185X.12582","volume":"18","author":"AU Uslu","year":"2015","unstructured":"Uslu AU, Kucuk A, Sahin A, Ugan Y, Yilmaz R, Gungor T, Bagcaci S, Kucuksen S. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: neutrophil\u2013lymphocyte ratio and platelet\u2013lymphocyte ratio. Int J Rheum Dis. 2015;18(7):731\u20135.","journal-title":"Int J Rheum Dis"},{"issue":"6","key":"454_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/1346-8138.12865","volume":"42","author":"DS Kim","year":"2015","unstructured":"Kim DS, Shin D, Jee H, Kim TG, Kim SH, Kim DY, Kim SM, Lee MG. Red blood cell distribution width is increased in patients with psoriasis vulgaris: a retrospective study on 261 patients. J Dermatol. 2015;42(6):567\u201371.","journal-title":"J Dermatol"},{"issue":"1","key":"454_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0923-1811(01)00121-9","volume":"27","author":"A Gornicki","year":"2001","unstructured":"Gornicki A, Gutsze A. Erythrocyte membrane fluidity changes in psoriasis: an EPR study. J Dermatol Sci. 2001;27(1):27\u201330.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"454_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/j.1365-2133.2004.05801.x","volume":"150","author":"P Rocha-Pereira","year":"2004","unstructured":"Rocha-Pereira P, Santos-Silva A, Rebelo I, Figneiredo A, Quintanilha A, Teixeira F. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol. 2004;150(2):232\u201344.","journal-title":"Br J Dermatol"},{"issue":"3","key":"454_CR30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaad.2011.01.022","volume":"66","author":"A Robinson","year":"2012","unstructured":"Robinson A, Kardos M, Kimball AB. Physician global assessment (PGA) and psoriasis area and severity index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis. J Am Acad Dermatol. 2012;66(3):369\u201375.","journal-title":"J Am Acad Dermatol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12865-021-00454-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-021-00454-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T11:05:10Z","timestamp":1632654310000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-021-00454-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["454"],"URL":"https:\/\/doi.org\/10.1186\/s12865-021-00454-4","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]},"assertion":[{"value":"12 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects in accordance with the Declaration of Helsinki. Written informed consent was not required for this retrospective study. The protocol was approved by the institutional review board of Peking Union Medical College Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not application.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}